Emanuel Denoia
San Antonio, TXNPI 1831236371
Payments from drug & device makers
No general payments reported
No drug or device maker reported general payments to this provider for 2019–2025. That is a common and unremarkable result.
$6,368,819in research payments, 2019–2025
Across 53 payments — averaging $120,166 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Global Blood Therapeutics, Inc.$3.6M
- Tris Pharma Inc$2.7M
- Eli Lilly$108K
- Bristol Myers Squibb$116
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.